prognoses for patients with solid brain tumors are based on a variety of pa
tient characteristics and on the histological type and grade of the tumor;
however, there are well-recognized subpopulations of patients with particul
ar types and grades of tumors for which this patient and histologic informa
tion unreliably predicts prognosis, in an effort to improve brain tumor pro
gnostic accuracy, especially in these difficult cases, recent intensive inv
estigation has been devoted to identifying molecular markers of prognosis i
n brain tumors. The usefulness of five widely-studied potential prognostic
markers (MIB-1, telomerase, p53/EGFR, BCL-2) is discussed, based on current
evidence in the literature.